Ranibizumab (anti-VEGF) | 347396-82-1 - MedChemExpress
MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報,我們不為任何個人用途提供產(chǎn)品和服務(wù)。
Ranibizumab (anti-VEGF)
品牌:MedChemExpress (MCE)
Drug_Names:Ranibizumab (anti-VEGF)
CAS:347396-82-1
產(chǎn)品活性:Ranibizumab (RG-6321) (anti-VEGF) 是一種人源化的抗 VEGF 單克隆抗體片段,能夠識別所有 VEGF-A 亞型 (VEGF110,VEGF121,以及 VEGF165)。動物模型中,Ranibizumab (anti-VEGF) 減緩視力喪失,并用于老年黃斑變性 (AMD) 的研究。
存儲條件:Please store the product under the recommended conditions in the Certificate of Analysis.
參考文獻(xiàn):
Mustafa ?ahiner, et al. The Effects of Anti-Vascular Endothelial Growth Factor Drugs on Retinal Pigment Epithelial Cell Culture. Turk J Ophthalmol. 2018 Aug;48(4):190-195.
K J Kim, et al. The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies. Growth Factors. 1992;7(1):53-64.
Richard Filek, et al. Safety of anti-VEGF treatments in a diabetic rat model and retinal cell culture. Clin Ophthalmol. 2019 Jul 1;13:1097-1114.